• Search History (Register)
  • MeSH Browser
  • [Clear]
    • English

Welcome to the international HTA database


Showing [16861 Records] Selected Records [0 Hits] [Clear]
Year Source Title
2012     HAYES, Inc. Negative pressure wound therapy in the adjunct treatment of skin grafts
2012     HAYES, Inc. Percutaneous kyphoplasty
2012     HAYES, Inc. Pharmacokinetically guided dose adjustment of 5-fluorouracil (5-FU)
2012     HAYES, Inc. Percutaneous vertebroplasty
2012     HAYES, Inc. Radiofrequency ablation for sacroiliac joint pain
2012     Agenzia sanitaria e sociale regionale, Regione Emilia-Romagna (ASSR) Criteria for appropriate use of FDG-PET in lung cancer
2012     National Institute for Health and Care Excellence (NICE) PeritX peritoneal catheter drainage system for vacuum-assisted drainage of treatment-resistant, recurrent malignant ascites. NICE medical technologies guidance 9
2012     HAYES, Inc. Telerehabilitation for musculoskeletal conditions, neuromuscular conditions, and mobility impairment
2012     NIHR Horizon Scanning Centre (NIHR HSC) UPDATED: Amniotic fluid lactate™ monitoring system for dysfunctional labour
2012     HAYES, Inc. Recombinant growth hormone treatment for AIDS/HIV-associated wasting and lipodystrophy
2012     HAYES, Inc. Topical antiseptic products for preoperative skin preparation
2012     NIHR Horizon Scanning Centre (NIHR HSC) Masitinib for severe asthma
2012     HAYES, Inc. Sialoendoscopy for salivary gland stones
2012     Technology Assessment Unit of the McGill University Health Centre (MUHC) The clinical effectiveness and cost of a pneumococcal urine antigen immunochromatographic test (BinaxNOW Streptococcus pneumoniae) in the diagnosis of community acquire Streptococcus pneumoniae pneumonia in patients admitted to hospital
2012     HAYES, Inc. Transcatheter aortic valve implantation for aortic stenosis
2012     NIHR Horizon Scanning Centre (NIHR HSC) Omalizumab for chronic spontaneous urticaria – second line
2012     HAYES, Inc. Vision therapy for dyslexia and other reading and learning disabilities
2012     HAYES, Inc. Ultrasound-guided injections of joints of the extremities
2012     HAYES, Inc. Vitamin D supplementation in patients with osteoporosis
2012     HAYES, Inc. Whole body vibration for the promotion of bone growth in postmenopausal women
2012     NIHR Horizon Scanning Centre (NIHR HSC) UPDATED: OVA1™ test for the assessment of suspected ovarian cancer
2012     HAYES, Inc. Complement factor H (CFH) p.Tyr402His and age-related maculopathy susceptibility 2 (ARMS2) p.Ala69Ser polymorphism testing for susceptibility to age-related macular degeneration (AMD)
2012     NIHR Horizon Scanning Centre (NIHR HSC) UPDATED: Xpert MTB/RIF® test for tuberculosis
2012     HAYES, Inc. Cytochrome P450 21A2 (CYP21A2) testing in congenital adrenal hyperplasia
2012     Agency for Healthcare Research and Quality (AHRQ) Skin substitutes for treating chronic wounds
2012     NIHR Horizon Scanning Centre (NIHR HSC) UPDATED: RealTime mS9 Colorectal Cancer (CRC) Assay for the early detection of colorectal cancer
2012     HAYES, Inc. Factor V (F5) HR2 haplotype testing for hypercoagulability
2012     Agency for Healthcare Research and Quality (AHRQ) Management of asymptomatic carotid stenosis
2012     NIHR Horizon Scanning Centre (NIHR HSC) Bevacizumab (Avastin) in combination with trastuzumab and chemotherapy for HER2-positive, node-positive or high risk node-negative breast cancer – adjuvant therapy
2012     HAYES, Inc. Factor VII (F7) p.Arg353Gln polymorphism testing
2012     Health Information and Quality Authority (HIQA) Economic evaluation of repeat universal antenatal screening for HIV in the third trimester of pregnancy
2012     NIHR Horizon Scanning Centre (NIHR HSC) Everolimus (Afinitor) with trastuzumab and paclitaxel for HER2 positive locally advanced or metastatic breast cancer – first line
2012     HAYES, Inc. Factor XIIIA1 (F13A1) p.Val34Leu polymorphism testing
2012     NIHR Health Technology Assessment programme Managing Injuries of the Neck Trial (MINT): a randomised controlled trial of treatments for whiplash injuries
2012     NIHR Horizon Scanning Centre (NIHR HSC) Farletuzumab for ovarian cancer: relapsed, platinum-sensitive – in combination with carboplatin and a taxane
2012     HAYES, Inc. KRAS sequence variant analysis for predicting response to epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs) in the treatment of non-small cell lung cancer (NSCLC)
2012     Agenzia sanitaria e sociale regionale, Regione Emilia-Romagna (ASSR) Innovative medical devices for diabetes management
2012     NIHR Horizon Scanning Centre (NIHR HSC) NGR-TNF for malignant pleural mesothelioma – second line
2012     HAYES, Inc. Ryanodine receptor 1 (RYR1) testing for malignant hyperthermia susceptibility (MHS)
2012     NIHR Health Technology Assessment programme Clinical effectiveness, cost-effectiveness and service users' perceptions of early, well-resourced communication therapy following a stroke: a randomised controlled trial (the ACT NoW Study)
2012     NIHR Horizon Scanning Centre (NIHR HSC) Nintedanib (Vargatef) for epithelial ovarian, fallopian tube or primary peritoneal carcinoma: advanced (stage IIB-IV) – first or second line; in combination with carboplatin and paclitaxel following initial surgery, where indicated
2012     HAYES, Inc. Septin 9 (SEPT9) methylation analysis for colorectal cancer
2012     HAYES, Inc. Alair bronchial thermoplasty system for treatment of asthma
2012     NIHR Horizon Scanning Centre (NIHR HSC) Panobinostat (Faridak) for relapsed or refractory multiple myeloma
2012     HAYES, Inc. TP63-related disorders (ectrodactyly-ectodermal dysplasia-clefting [EEC3] syndrome; acro-dermato-ungual-lacrimal-tooth [ADULT] syndrome; ankyloblepharon-ectodermal dysplasia-clefting [AEC; hay-wells] syndrome; limb-mammary syndrome (LMS); nonsyndromic split-hand/split-foot malformation [SHFM4]; rapp-hodgkin syndrome [RHS])
2012     HAYES, Inc. Architect HE4 assay for ovarian cancer detection
2012     NIHR Horizon Scanning Centre (NIHR HSC) SAR-302503 for myelofibrosis – first line
2012     HAYES, Inc. Aquamantys system with transcollation technology (Medtronic Inc.) for hip arthroplasty
2012     HAYES, Inc. Artificial disc replacement for cervical degenerative disc disease
2012     NIHR Horizon Scanning Centre (NIHR HSC) HPV OncoTect® E6 E7 mRNA Assay to guide colposcopy referral in cervical cancer screening
2012     HAYES, Inc. Aquamantys system with transcollation technology (Medtronic Inc.) for liver resection
2012     HAYES, Inc. Computer-aided total hip arthroplasty
2012     NIHR Horizon Scanning Centre (NIHR HSC) Empagliflozin for type 2 diabetes mellitus
2012     HAYES, Inc. Argon plasma coagulation for hemostasis in patients with gastric antral vascular ectasia (GAVE)
2012     HAYES, Inc. Cryoablation for atrial fibrillation
2012     NIHR Horizon Scanning Centre (NIHR HSC) VBLOC® vagal blocking therapy for obesity
2012     HAYES, Inc. Autologous fat grafting for postmastectomy breast reconstruction
2012     HAYES, Inc. Deep brain stimulation for treatment-resistant depression
2012     NIHR Horizon Scanning Centre (NIHR HSC) Naloxegol (NKTR-118) for opioid-induced constipation
2012     All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG) Midazolam (BUCCOLAM®)
2012     HAYES, Inc. AxiaLIF (Axial Lumbar Interbody Fusion) system (TranS1 Inc.) for percutaneous lumbosacral surgery
2012     HAYES, Inc. Hexaminolevulinate (Cysview®, Hexvix®) for bladder cancer detection
2012     NIHR Horizon Scanning Centre (NIHR HSC) ALFApump® System for ascites due to liver cirrhosis
2012     All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG) Fluorouracil/salicylic acid (Actikerall®)
2012     HAYES, Inc. Cook celect vena cava filter (Cook Medical Inc.) for prophylaxis and treatment of pulmonary embolism
2012     HAYES, Inc. Home sleep studies for diagnosis of obstructive sleep apnea syndrome in patients younger than 18 years of age
2012     NIHR Horizon Scanning Centre (NIHR HSC) Collagenase clostridium histolyticum (Xiapex) for Dupuytren's contracture – first line
2012     HAYES, Inc. Doxorubicin drug-eluting bead transarterial chemoembolization (DEB-TACE) for patients with hepatocellular carcinoma (HCC)
2012     HAYES, Inc. Image-based computer-aided navigation for total knee arthroplasty
2012     NIHR Health Technology Assessment programme Pulse oximetry as a screening test for congenital heart defects in newborn infants: a test accuracy study with evaluation of acceptability and cost-effectiveness
2012     NIHR Health Technology Assessment programme Non-pharmacological interventions to reduce the risk of diabetes in people with impaired glucose regulation: a systematic review and economic evaluation
2012     NIHR Horizon Scanning Centre (NIHR HSC) Tolvaptan for autosomal dominant polycystic kidney disease
2012     All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG) Atorvastatin (Lipitor®) chewable tablets
2012     HAYES, Inc. Ganz trochanteric flip osteotomy approach to hip resurfacing for treatment of osteoarthritis
2012     HAYES, Inc. Imageless computer-aided navigation for total knee arthroplasty
2012     NIHR Horizon Scanning Centre (NIHR HSC) Transportable haemodialysis machines for established renal failure
2012     All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG) Trastuzumab (Herceptin®)
2012     HAYES, Inc. Home-based cervical traction for treatment of neck pain
2012     HAYES, Inc. Intacs for the treatment of keratoconus
2012     NIHR Horizon Scanning Centre (NIHR HSC) Secukinumab for plaque psoriasis
2012     All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG) Linagliptin (Trajenta®)
2012     HAYES, Inc. Lifevest system (Asahi Kasei Corp.) wearable cardiac defibrillator for prevention of sudden cardiac arrest
2012     HAYES, Inc. Intravenous immunoglobulin for chronic inflammatory demyelinating polyneuropathy
2012     NIHR Health Technology Assessment programme The use of MElatonin in children with Neurodevelopmental Disorders and impaired Sleep: a randomised, double-blind, placebo-controlled, parallel study (MENDS)
2012     NIHR Horizon Scanning Centre (NIHR HSC) Brivanib alaninate for hepatocellular cancer
2012     All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG) Esomeprazole (Nexium® IV)
2012     HAYES, Inc. Minimally invasive lumbar decompression (mild; Vertos Medical Inc.) for lumbar spinal stenosis
2012     HAYES, Inc. Intravenous immunoglobulin for myasthenia gravis
2012     NIHR Horizon Scanning Centre (NIHR HSC) Cilengitide (Impetreve) for glioblastoma multiforme
2012     All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG) Adalimumab (Humira®)
2012     HAYES, Inc. Outpatient cervical traction for treatment of neck pain
2012     HAYES, Inc. Intravenous immunoglobulin for pulmonary diseases
2012     Health Information and Quality Authority (HIQA) Health technology assessment of robot-assisted surgery in Ireland
2012     NIHR Horizon Scanning Centre (NIHR HSC) Clofarabine (Evoltra) for acute myeloid leukaemia in older adults unsuitable for anthracycline-based combination chemotherapy
2012     All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG) Capsaicin 8% patch (Qutenza®)
2012     HAYES, Inc. Tearlab osmolarity system (TearLab Corp.) for diagnosis of dry eye disease
2012     NIHR Horizon Scanning Centre (NIHR HSC) Everolimus (Afinitor) in combination with trastuzumab and vinorelbine for HER2/neu positive, locally advanced or metastatic breast cancer
2012     All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG) Entecavir (Baraclude®)
2012     HAYES, Inc. Third eye retroscope (Avantis Medical Systems Inc.) for aiding the colonoscopic detection of colorectal polyps and adenomas
2012     NIHR Horizon Scanning Centre (NIHR HSC) Iniparib (Tivolza) in combination with gemcitabine and carboplatin for stage IV squamous non-small cell lung cancer